December 20, 2005
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Fugo Blade approved for additional uses
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The Fugo Blade has been approved by U.S. regulators for additional indications, according to the device’s maker, Medisurg Ltd. The newly approved indications include peripheral iridotomy creation for angle closure glaucoma and with anterior chamber or phakic IOLs, Medisurg said in a press release.
The Fugo blade is already marketed in the United States for capsulotomy and for transciliary filtration, also known as Singh filtration.
The new applications allow surgeons “to place the peripheral iridotomy in an exact location with an exact size” by touching the iris at the desired point of iridotomy with the blunt tip of the blade, according to Medisurg. The iridotomy is created by plasma ablation of the iris tissue.